Recombinant Human CCL2 Protein，His

CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), is a crucial chemokine involved in the recruitment of monocytes and other immune cells to sites of inflammation and injury. Its role in various physiological and pathological processes, such as immune response, tissue remodeling, and disease progression, has made it a significant target for research. Overexpression of CCL2 has been implicated in several conditions, including autoimmune diseases, cancer, and cardiovascular diseases, highlighting its importance in disease mechanisms. The production of recombinant CCL2 protein allows for detailed studies into its biological functions, interactions with receptors, and potential therapeutic applications. Researchers utilize recombinant techniques to generate CCL2 in sufficient quantities for in vitro and in vivo experiments, facilitating investigations into its signaling pathways and effects on immune cell behavior. Furthermore, understanding the structure-function relationship of CCL2 through recombinant protein studies can lead to the development of novel strategies for managing diseases linked to dysregulated inflammation. Thus, the research into CCL2 recombinant protein not only enhances our comprehension of its fundamental biology but also opens avenues for innovative therapeutic interventions targeting inflammatory and immune-related disorders.